Target intelligence / Profile preview

Amphiphysin pseudogene

Molecular classification: Other (specifically, pseudogene)

Overview

Amphiphysin pseudogene (ENSG00000230087, also known as LOC100418885) is a non-functional genetic sequence classified as a pseudogene and related to the functional Amphiphysin gene (AMPH)[1][3]. Pseudogenes arise from gene duplication or retrotransposition and do not encode active proteins. This means ENSG00000230087 itself is not involved in biological processes or disease mechanisms and is not considered a drug target[1][3]. Information on therapeutic targeting, drug interactions, or disease associations pertains only to the protein-coding gene Amphiphysin (AMPH), not to its pseudogene[3].

Other names: LOC100418885Amphiphysin pseudogene

Beyond the preview

Go deeper on Amphiphysin pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amphiphysin pseudogene.

Explore the full profile